IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 125 filers reported holding IMMUNOVANT INC in Q1 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,487,221 | -25.3% | 236,543 | -38.9% | 0.02% | -30.0% |
| Q1 2023 | $6,007,287 | +64.4% | 387,317 | +88.2% | 0.03% | +50.0% |
| Q4 2022 | $3,653,554 | +137.7% | 205,834 | +14.1% | 0.02% | +150.0% |
| Q4 2021 | $1,537,000 | -51.7% | 180,395 | -50.7% | 0.01% | -60.0% |
| Q3 2021 | $3,179,000 | -18.4% | 365,793 | -0.8% | 0.02% | -25.9% |
| Q2 2021 | $3,897,000 | -43.5% | 368,729 | -14.3% | 0.03% | -46.0% |
| Q1 2021 | $6,897,000 | – | 430,015 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |